The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)

Publisher： Spandidos Publications

E-ISSN： 1791-2423|45|6|2267-2277

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.45, Iss.6, 2014-01, pp. : 2267-2277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells

By Murakami Masahiro  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 589-596

Springer Publishing Company

Access to resources Recommend Favorite

Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases

By Lee Lucy   Sharma Sunil   Morgan Bruno   Allegrini Peter   Schnell Christian   Brueggen Josef   Cozens Robert   Horsfield Mark   Guenther Clemens   Steward Will   Drevs Joachim   Lebwohl David   Wood Jeanette   McSheehy Paul  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 761-771

Springer Publishing Company

Access to resources Recommend Favorite

PTK787/ZK222584 Combined with Interferon Alpha and 5-Fluorouracil Synergistically Inhibits VEGF Signaling Pathway in Hepatocellular Carcinoma

By Katsura Yoshiteru   Wada Hiroshi   Murakami Masahiro   Akita Hirofumi   Hama Naoki   Kawamoto Koichi   Kobayashi Shogo   Marubashi Shigeru   Eguchi Hidetoshi   Tanemura Masahiro   Umeshita Koji   Doki Yuichiro   Mori Masaki   Nagano Hiroaki  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 517-526

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas

By Raizer Jeffrey   Grimm Sean   Rademaker Alfred   Chandler James   Muro Kenji   Helenowski Irene   Rice Laurie   McCarthy Katie   Johnston Sandra   Mrugala Maciej   Chamberlain Marc  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 93-101

Springer Publishing Company

Access to resources Recommend Favorite

Is EGF receptor–tyrosine kinase inhibitor therapy in non-small-cell lung cancer patients with EGFR mutations the best option?

By Hayashi Hidetoshi   Nakagawa Kazuhiko  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 441-443

Future Medicine

Access to resources Recommend Favorite